ホーム › 腎臓がん（腎細胞がん） › オレゴン
オレゴンにおける腎臓がん（腎細胞がん）の臨床試験
オレゴン内の拠点で、腎臓がん（腎細胞がん）に関する11件の研究が参加者を募集しています。
オレゴン内の都市
公式研究テキスト（英語）
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- 他7件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #51, Portland
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05176483Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT03866382Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Northwest Cancer Specialists, P.C., Portland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
- Providence Newberg Medical Center, Newberg
- Providence Willamette Falls Medical Center, Oregon City
- Providence Portland Medical Center, Portland
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06661720A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Providence Cancer Center Oncology and Hematology Care- Eastside, Portland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709A Study of MGC026 in Participants With Advanced Solid Tumors
- Providence Cancer Institute, Portland
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Oregon Health & Science University (3485 S. Bond), Portland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/09更新 · NCT03972657Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
- OHSU Knight Cancer Institute, Portland
被験者募集中第4相
18歳以上 · 全性別 · 2026/06/12更新 · NCT07405086A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
- Oregon Health & Science University, Portland
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/23更新 · NCT06805825Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Kaiser Sunnyside Medical Center, Clackamas
- Kaiser Permanente Northwest, Portland
- Oregon Health and Science University, Portland
被験者募集中第3相
18歳以上 · 全性別 · 2025/09/09更新 · NCT04510597ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。